Bronchopulmonary dysplasia drug (Chiesi Farmaceutici SpA)

N/A

Report date: 2025/01/26 17:55:31
NME

Base Information

Drug NameBronchopulmonary dysplasia drug (Chiesi Farmaceutici SpA)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLung Malformation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesChiesi Farmaceutici SPA
China Registration ClassN/A

Develop Information

Active CompaniesChiesi Farmaceutici SPA
Inactive CompaniesN/A
Active IndicationsLung Malformation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A